Edition:
United States

Precipio Inc (PRPO.OQ)

PRPO.OQ on NASDAQ Stock Exchange Capital Market

1.09USD
3:59pm EST
Change (% chg)

$-0.04 (-3.54%)
Prev Close
$1.13
Open
$1.14
Day's High
$1.14
Day's Low
$1.09
Volume
1,615
Avg. Vol
14,430
52-wk High
$28.16
52-wk Low
$1.09

Chart for

About

Precipio, Inc., formerly Transgenomic, Inc., is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment.... (more)
No analyst recommendations are available for .

Overall

Beta: -0.04
Market Cap(Mil.): $11.43
Shares Outstanding(Mil.): 10.03
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Precipio Q3 sales fell 26 percent

* Precipio announces third quarter 2017 financial results and provides corporate update

Nov 20 2017

BRIEF-Precipio Inc files for non-timely 10-Q

* Precipio Inc files for non-timely 10-Q - SEC filing‍​ Source text: (http://bit.ly/2yyJYDg) Further company coverage:

Nov 13 2017

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF241.70 +1.10
Roche Holding Ltd. (RO.S) CHF244.00 +0.80
Sanofi SA (SASY.PA) €75.03 --
Qiagen NV (QGEN.OQ) $31.67 +0.41
Sequenom, Inc. (SQNM.OQ) -- --
Merck KGaA (MRCG.DE) €91.16 +1.32

Earnings vs. Estimates